The DOI matches its Crossref record; 192 of the 192 references it cites were found in a registry or an index.
Design considerations for liposomal vaccines: Influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens
Open accessAbstract
Liposomes (phospholipid bilayer vesicles) are versatile and robust delivery systems for induction of antibody and T lymphocyte responses to associated subunit antigens. In the last 15 years, liposome vaccine technology has matured and now several vaccines containing liposome-based adjuvants have been approved for human use or have reached late stages of clinical evaluation. Given the intensifying interest in liposome-based vaccines, it is important to understand precisely how liposomes interact with the immune system and stimulate immunity. It has become clear that the physicochemical properties of liposomal vaccines – method of antigen attachment, lipid composition, bilayer fluidity, particle charge, and other properties – exert dramatic effects on the resulting immune response. Here, we present a comprehensive review of the physicochemical properties of liposomal vaccines and how they influence immune responses. A discussion of novel and emerging immunomodulators that are suitable for inclusion in liposomal vaccines is also presented. Through a comprehensive analysis of the body of liposomal vaccine literature, we enumerate a series of principles that can guide the rational design of liposomal vaccines to elicit immune responses of a desired magnitude and quality. We also identify major unanswered questions in the field, pointing the direction for future study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Of Mice and Not Men: Differences between Mouse and Human Immunology
Mestas, J., & Hughes, C. C. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2731 · Cited by 3,822
M-1/M-2 Macrophages and the Th1/Th2 Paradigm
Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J., & Hill, A. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6166 · Cited by 3,287
Hornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
Matloubian, M., Lo, C. G., Cinamon, G., Lesneski, M. J., Xu, Y., Brinkmann, V., Allende, M. L., Proia, R. L., & Cyster, J. G. (2004) · Nature · doi:10.1038/nature02284 · Cited by 2,581
CD1d-Restricted and TCR-Mediated Activation of V α 14 NKT Cells by Glycosylceramides
Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., et al. (1997) · Science · doi:10.1126/science.278.5343.1626 · Cited by 2,400
Szoka, F., & Papahadjopoulos, D. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.9.4194 · Cited by 2,323
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
BLACK, S., SHINEFIELD, H., FIREMAN, B., LEWIS, E., RAY, P., HANSEN, J. R., ELVIN, L., ENSOR, K. M., HACKELL, J., SIBER, G., et al. (2000) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200003000-00003 · Cited by 2,293
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Bachmann, M. F., & Jennings, G. T. (2010) · Nature Reviews Immunology · doi:10.1038/nri2868 · Cited by 2,106
Reciprocal T H 17 and Regulatory T Cell Differentiation Mediated by Retinoic Acid
Mucida, D., Park, Y., Kim, G., Turovskaya, O., Scott, I., Kronenberg, M., & Cheroutre, H. (2007) · Science · doi:10.1126/science.1145697 · Cited by 1,982
Fatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling
Wen, H., Gris, D., Lei, Y., Jha, S., Zhang, L., Huang, M. T.-H., Brickey, W. J., & Ting, J. P.-Y. (2011) · Nature Immunology · doi:10.1038/ni.2022 · Cited by 1,698
Holmgren, J., & Czerkinsky, C. (2005) · Nature Medicine · doi:10.1038/nm1213 · Cited by 1,562
Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120
Hirasawa, A., Tsumaya, K., Awaji, T., Katsuma, S., Adachi, T., Yamada, M., Sugimoto, Y., Miyazaki, S., & Tsujimoto, G. (2005) · Nature Medicine · doi:10.1038/nm1168 · Cited by 1,545
Retinoic acid imprints gut-homing specificity on T cells
Iwata, M., Hirakiyama, A., Eshima, Y., Kagechika, H., Kato, C., & Song, S.-Y. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.011 · Cited by 1,541
Comparative Properties and Methods of Preparation of Lipid Vesicles (Liposomes)
Szoka, F., & Papahadjopoulos, D. (1980) · Annual Review of Biophysics and Bioengineering · doi:10.1146/annurev.bb.09.060180.002343 · Cited by 1,515
A receptor for phosphatidylserine-specific clearance of apoptotic cells
Fadok, V. A., Bratton, D. L., Rose, D. M., Pearson, A., Ezekewitz, R. A. B., & Henson, P. M. (2000) · Nature · doi:10.1038/35011084 · Cited by 1,491
Improved method for predicting linear B-cell epitopes.
Larsen, J., Lund, O., & Nielsen, M. (2006) · Immunome Research · doi:10.1186/1745-7580-2-2 · Cited by 1,413
Signalling through C-type lectin receptors: shaping immune responses
Geijtenbeek, T. B. H., & Gringhuis, S. I. (2009) · Nature Reviews Immunology · doi:10.1038/nri2569 · Cited by 1,379
Bonifaz, L., Bonnyay, D., Mahnke, K., Rivera, M., Nussenzweig, M. C., & Steinman, R. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021598 · Cited by 1,306
Liposomes in drug delivery: Progress and limitations
Sharma, A. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00135-x · Cited by 1,253
Veldhoen, M., Uyttenhove, C., van Snick, J., Helmby, H., Westendorf, A., Buer, J., Martin, B., Wilhelm, C., & Stockinger, B. (2008) · Nature Immunology · doi:10.1038/ni.1659 · Cited by 1,213
The immunology of susceptibility and resistance to Leishmania major in mice
Sacks, D., & Noben-Trauth, N. (2002) · Nature Reviews Immunology · doi:10.1038/nri933 · Cited by 1,208
Intracellular pattern recognition receptors in the host response
Meylan, E., Tschopp, J., & Karin, M. (2006) · Nature · doi:10.1038/nature04946 · Cited by 1,206
Mechanism of DNA Release from Cationic Liposome/DNA Complexes Used in Cell Transfection,
Xu, Y., & Szoka, F. C. (1996) · Biochemistry · doi:10.1021/bi9602019 · Cited by 1,134
Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans
Querec, T. D., Akondy, R. S., Lee, E. K., Cao, W., Nakaya, H. I., Teuwen, D., Pirani, A., Gernert, K., Deng, J., Marzolf, B., et al. (2009) · Nature Immunology · doi:10.1038/ni.1688 · Cited by 1,121
The Orphan G Protein-coupled Receptor GPR40 Is Activated by Medium and Long Chain Fatty Acids
Briscoe, C. P., Tadayyon, M., Andrews, J. L., Benson, W. G., Chambers, J. K., Eilert, M. M., Ellis, C., Elshourbagy, N. A., Goetz, A. S., Minnick, D. T., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211495200 · Cited by 1,104
Chloride Accumulation and Swelling in Endosomes Enhances DNA Transfer by Polyamine-DNA Polyplexes
Sonawane, N. D., Szoka, F. C., & Verkman, A. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308643200 · Cited by 1,081
Intracellular NOD-like Receptors in Host Defense and Disease
Kanneganti, T.-D., Lamkanfi, M., & Núñez, G. (2007) · Immunity · doi:10.1016/j.immuni.2007.10.002 · Cited by 1,061
Programming the magnitude and persistence of antibody responses with innate immunity
Kasturi, S. P., Skountzou, I., Albrecht, R. A., Koutsonanos, D., Hua, T., Nakaya, H. I., Ravindran, R., Stewart, S., Alam, M., Kwissa, M., et al. (2011) · Nature · doi:10.1038/nature09737 · Cited by 975
First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children
The RTS, S. C. T. P. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102287 · Cited by 896
Towards an understanding of the adjuvant action of aluminium
Marrack, P., McKee, A. S., & Munks, M. W. (2009) · Nature Reviews Immunology · doi:10.1038/nri2510 · Cited by 887
Cross-Presentation, Dendritic Cells, Tolerance and Immunity
Heath, W. R., & Carbone, F. R. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.47 · Cited by 882
Wang, P., Sidney, J., Dow, C., Mothé, B., Sette, A., & Peters, B. (2008) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000048 · Cited by 844
LPA Receptors: Subtypes and Biological Actions
Choi, J. W., Herr, D. R., Noguchi, K., Yung, Y. C., Lee, C.-W., Mutoh, T., Lin, M.-E., Teo, S. T., Park, K. E., Mosley, A. N., et al. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105753 · Cited by 839
T Cell-Independent Antigens Type 2
Mond, J. J. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.655 · Cited by 824
The who, how and where of antigen presentation to B cells
Batista, F. D., & Harwood, N. E. (2009) · Nature Reviews Immunology · doi:10.1038/nri2454 · Cited by 775
Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting
Tacken, P. J., de Vries, I. J. M., Torensma, R., & Figdor, C. G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2173 · Cited by 750
Liposomes as immunological adjuvants
ALLISON, A. C., & GREGORIADIS, G. (1974) · Nature · doi:10.1038/252252a0 · Cited by 675
Lipid-based Nanoparticles for Nucleic Acid Delivery
Li, W., & Szoka, F. C. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9180-5 · Cited by 641
Prediction of residues in discontinuous B‐cell epitopes using protein 3D structures
Haste Andersen, P., Nielsen, M., & Lund, O. (2006) · Protein Science · doi:10.1110/ps.062405906 · Cited by 634
The alliance of sphingosine-1-phosphate and its receptors in immunity
Rivera, J., Proia, R. L., & Olivera, A. (2008) · Nature Reviews Immunology · doi:10.1038/nri2400 · Cited by 616
Structure-Activity Relationship of .alpha.-Galactosylceramides against B16-Bearing Mice
Morita, M., Motoki, K., Akimoto, K., Natori, T., Sakai, T., Sawa, E., Yamaji, K., Koezuka, Y., Kobayashi, E., & Fukushima, H. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00012a018 · Cited by 599
RNA recognition and signal transduction by RIG‐I‐like receptors
Yoneyama, M., & Fujita, T. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00727.x · Cited by 598
Kirby, C., Clarke, J., & Gregoriadis, G. (1980) · Biochemical Journal · doi:10.1042/bj1860591 · Cited by 592
Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction
Trotter, C. L., Andrews, N. J., Kaczmarski, E. B., Miller, E., & Ramsay, M. E. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16725-1 · Cited by 571
Ahsan, F. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00549-1 · Cited by 570
Paus, D., Phan, T. G., Chan, T. D., Gardam, S., Basten, A., & Brink, R. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060087 · Cited by 567
Moon, J. J., Suh, H., Bershteyn, A., Stephan, M. T., Liu, H., Huang, B., Sohail, M., Luo, S., Ho Um, S., Khant, H., et al. (2011) · Nature Materials · doi:10.1038/nmat2960 · Cited by 564
Wong, S. W., Kwon, M.-J., Choi, A. M. K., Kim, H.-P., Nakahira, K., & Hwang, D. H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.044065 · Cited by 562
Adjuvants for human vaccines—current status, problems and future prospects
Gupta, R. K., & Siber, G. R. (1995) · Vaccine · doi:10.1016/0264-410x(95)00011-o · Cited by 551
Merkel, T. J., Jones, S. W., Herlihy, K. P., Kersey, F. R., Shields, A. R., Napier, M., Luft, J. C., Wu, H., Zamboni, W. C., Wang, A. Z., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010013108 · Cited by 548
Mechanisms and consequences of cellular cholesterol exchange and transfer
Phillips, M. C., Johnson, W. J., & Rothblat, G. H. (1987) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(87)90013-x · Cited by 541
Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome
Sharp, F. A., Ruane, D., Claass, B., Creagh, E., Harris, J., Malyala, P., Singh, M., O'Hagan, D. T., Pétrilli, V., Tschopp, J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804897106 · Cited by 540
Miller, C. R., Bondurant, B., McLean, S. D., McGovern, K. A., & O'Brien, D. F. (1998) · Biochemistry · doi:10.1021/bi980096y · Cited by 524
INNATE IMMUNE RESPONSE IN TH1- AND TH2-DOMINANT MOUSE STRAINS
Watanabe, H., Numata, K., Ito, T., Takagi, K., & Matsukawa, A. (2004) · Shock · doi:10.1097/01.shk.0000142249.08135.e9 · Cited by 519
Singh, M., & O'Hagan, D. (1999) · Nature Biotechnology · doi:10.1038/15058 · Cited by 506
Schoenen, H., Bodendorfer, B., Hitchens, K., Manzanero, S., Werninghaus, K., Nimmerjahn, F., Agger, E. M., Stenger, S., Andersen, P., Ruland, J., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904013 · Cited by 492
Muñoz, N., Manalastas, R., Pitisuttithum, P., Tresukosol, D., Monsonego, J., Ault, K., Clavel, C., Luna, J., Myers, E., Hood, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60691-7 · Cited by 478
(2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.00607.x · Cited by 472
Induction of secretory immunity and memory at mucosal surfaces
Brandtzaeg, P. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.12.001 · Cited by 472
Alexopoulou, L., Thomas, V., Schnare, M., Lobet, Y., Anguita, J., Schoen, R. T., Medzhitov, R., Fikrig, E., & Flavell, R. A. (2002) · Nature Medicine · doi:10.1038/nm732 · Cited by 435
Recent advances in the discovery and delivery of vaccine adjuvants
O'Hagan, D. T., & Valiante, N. M. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1176 · Cited by 434
Prophylactic human papillomavirus vaccines
Lowy, D. R. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28607 · Cited by 428
Randomized Phase IIB Trial of BLP25 Liposome Vaccine in Stage IIIB and IV Non–Small-Cell Lung Cancer
Butts, C., Murray, N., Maksymiuk, A., Goss, G., Marshall, E., Soulières, D., Cormier, Y., Ellis, P., Price, A., Sawhney, R., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.13.011 · Cited by 428
The global impact of vaccination against hepatitis B: A historical overview
Zanetti, A. R., Van Damme, P., & Shouval, D. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.09.056 · Cited by 420
Mabrey, S., Mateo, P. L., & Sturtevant, J. M. (1978) · Biochemistry · doi:10.1021/bi00605a034 · Cited by 408
Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens
DePaolo, R. W., Abadie, V., Tang, F., Fehlner-Peach, H., Hall, J. A., Wang, W., Marietta, E. V., Kasarda, D. D., Waldmann, T. A., Murray, J. A., et al. (2011) · Nature · doi:10.1038/nature09849 · Cited by 392
Falsey, A. R., Treanor, J. J., Tornieporth, N., Capellan, J., & Gorse, G. J. (2009) · The Journal of Infectious Diseases · doi:10.1086/599790 · Cited by 388
Lymphatic uptake and biodistribution of liposomes after subcutaneous injection.
Oussoren, C., Zuidema, J., Crommelin, D. J. A., & Storm, G. (1997) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(97)00122-3 · Cited by 380
Stewart, S., Jablonowski, H., Goebel, F. D., Arasteh, K., Spittle, M., Rios, A., Aboulafia, D., Galleshaw, J., & Dezube, B. J. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.683 · Cited by 358
Siegel, D. P., & Epand, R. M. (1997) · Biophysical Journal · doi:10.1016/s0006-3495(97)78336-x · Cited by 353
Liposomes as carriers of antigens and adjuvants
Alving, C. R. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90120-5 · Cited by 344
Vaccine adjuvant systems: Enhancing the efficacy of sub-unit protein antigens
Perrie, Y., Mohammed, A. R., Kirby, D. J., McNeil, S. E., & Bramwell, V. W. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.04.036 · Cited by 333
Legendre, J.-Y., & Szoka Jr, F. C. (1992) · Pharmaceutical Research · doi:10.1023/a:1015836829670 · Cited by 332
Cholera toxin and cholera B subunit as oral—mucosal adjuvant and antigen vector systems
Holmgren, J., Lycke, N., & Czerkinsky, C. (1993) · Vaccine · doi:10.1016/0264-410x(93)90039-z · Cited by 325
Immunity in response to particulate antigen-delivery systems
STORNI, T., KUNDIG, T., SENTI, G., & JOHANSEN, P. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.008 · Cited by 317
Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems
Garçon, N., & Van Mechelen, M. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.29 · Cited by 314
Weatherill, A. R., Lee, J. Y., Zhao, L., Lemay, D. G., Youn, H. S., & Hwang, D. H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5390 · Cited by 312
Nanoparticulates as Drug Carriers
Torchilin, V. P. (2006) · IMPERIAL COLLEGE PRESS eBooks · doi:10.1142/9781860949074 · Cited by 309
Kozlowski, P. A., Cu-Uvin, S., Neutra, M. R., & Flanigan, T. P. (1997) · Infection and Immunity · doi:10.1128/iai.65.4.1387-1394.1997 · Cited by 294
Eleven years of Inflexal® V—a virosomal adjuvanted influenza vaccine
Herzog, C., Hartmann, K., Künzi, V., Kürsteiner, O., Mischler, R., Lazar, H., & Glück, R. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.05.029 · Cited by 292
Stamatatos, L., Leventis, R., Zuckermann, M. J., & Silvius, J. R. (1988) · Biochemistry · doi:10.1021/bi00411a005 · Cited by 286
Saturated Fatty Acids Do Not Directly Stimulate Toll-Like Receptor Signaling
Erridge, C., & Samani, N. J. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.194050 · Cited by 260
Cationic liposomes as vaccine adjuvants
Christensen, D., Korsholm, K. S., Andersen, P., & Agger, E. M. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.17 · Cited by 259
The virosome concept for influenza vaccines
Huckriede, A., Bungener, L., Stegmann, T., Daemen, T., Medema, J., Palache, A. M., & Wilschut, J. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.04.026 · Cited by 250
Nanoparticulates as Drug Carriers
Torchilin, V. P. (2006) · IMPERIAL COLLEGE PRESS eBooks · doi:10.1142/p432 · Cited by 248
Zaks, K., Jordan, M., Guth, A., Sellins, K., Kedl, R., Izzo, A., Bosio, C., & Dow, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7335 · Cited by 242
Lee, K.-D., Hong, K., & Papahadjopoulos, D. (1992) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(92)90086-2 · Cited by 240
Epaxal®: a virosomal vaccine to prevent hepatitis A infection
Bovier, P. A. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.7.8.1141 · Cited by 233
Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy.
Fries, L. F., Gordon, D. M., Richards, R. L., Egan, J. E., Hollingdale, M. R., Gross, M., Silverman, C., & Alving, C. R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.358 · Cited by 228
Li, S., Wu, S.-P., Whitmore, M., Loeffert, E. J., Wang, L., Watkins, S. C., Pitt, B. R., & Huang, L. (1999) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1999.276.5.l796 · Cited by 225
Self-citationLiposome-mediated DNA vaccination: the effect of vesicle composition
Perrie, Y., Frederik, P. M., & Gregoriadis, G. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00432-1 · Cited by 210
Camuesco, D., Gálvez, J., Nieto, A., Comalada, M., Rodríguez-Cabezas, M. E., Concha, A., Xaus, J., & Zarzuelo, A. (2005) · The Journal of Nutrition · doi:10.1093/jn/135.4.687 · Cited by 200
LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth
Whitmore, M., Li, S., & Huang, L. (1999) · Gene Therapy · doi:10.1038/sj.gt.3301026 · Cited by 199
Self-citationHenriksen-Lacey, M., Bramwell, V. W., Christensen, D., Agger, E.-M., Andersen, P., & Perrie, Y. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.022 · Cited by 196
Poland, G. A., Ovsyannikova, I. G., Jacobson, R. M., & Smith, D. I. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100415 · Cited by 193
Zhu, Q., Egelston, C., Gagnon, S., Sui, Y., Belyakov, I. M., Klinman, D. M., & Berzofsky, J. A. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39293 · Cited by 186
Inflexal®V a trivalent virosome subunit influenza vaccine: production
Mischler, R., & Metcalfe, I. C. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00512-1 · Cited by 183
Idzko, M., Panther, E., Corinti, S., Morelli, A., Ferrari, D., Herouy, Y., Dichmann, S., Mockenhaupt, M., Gebicke-Haerter, P., Di Virgilio, F., et al. (2002) · The FASEB Journal · doi:10.1096/fj.01-0625fje · Cited by 183
McConville, M. J., Bacic, A., Mitchell, G. F., & Handman, E. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.8941 · Cited by 179
Henriksen‐Lacey, M., Christensen, D., Bramwell, V. W., Lindenstrøm, T., Agger, E. M., Andersen, P. L., & Perrie, Y. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.03.027 · Cited by 175
Nair, S., Zhou, F., Reddy, R., Huang, L., & Rouse, B. T. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.2.609 · Cited by 175
Self-citationHolten-Andersen, L., Doherty, T. M., Korsholm, K. S., & Andersen, P. (2004) · Infection and Immunity · doi:10.1128/iai.72.3.1608-1617.2004 · Cited by 172
Niosomes in sustained and targeted drug delivery: some recent advances
Azeem, A., Anwer, M. K., & Talegaonkar, S. (2009) · Journal of drug targeting · doi:10.3109/10611860903079454 · Cited by 171
Liposomal vaccine delivery systems
Henriksen‐Lacey, M., Korsholm, K. S., Andersen, P. L., Perrie, Y., & Christensen, D. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.558081 · Cited by 168
Lipid Vesicle Size Determines the Th1 or Th2 Response to Entrapped Antigen
Brewer, J. M., Tetley, L., Richmond, J. A., Liew, F. Y., & Alexander, J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.8.4000 · Cited by 167
Mann, J. F. S., Shakir, E., Carter, K. C., Mullen, A. B., Alexander, J., & Ferro, V. A. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.03.040 · Cited by 166
Retinoic acid-dependent regulation of immune responses by dendritic cells and macrophages
Manicassamy, S., & Pulendran, B. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2008.07.007 · Cited by 165
Loveren, H. V., van Amsterdam, J., Vandebriel, R. J., Kimman, T. G., Rümke, H. C., Steerenberg, P., & Vos, J. G. (2001) · Environmental Health Perspectives · doi:10.1289/ehp.01109757 · Cited by 151
Currently approved prophylactic HPV vaccines
Harper, D. M. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.123 · Cited by 150
Nakanishi, T., Kunisawa, J., Hayashi, A., Tsutsumi, Y. M., Kubo, K., Nakagawa, S., Nakanishi, M., Tanaka, K., & Mayumi, T. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00097-8 · Cited by 149
The effects of charge and size on the interaction of unilamellar liposomes with macrophages
Schwendener, R. A., Lagocki, P., & Rahman, Y. E. (1984) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(84)90521-2 · Cited by 147
Cationic liposomes as vaccine adjuvants
Christensen, D., Korsholm, K. S., Rosenkrands, I., Lindenstrøm, T., Andersen, P. L., & Agger, E. M. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.5.785 · Cited by 138
Influenza control in the 21st century: Optimizing protection of older adults
Monto, A. S., Ansaldi, F., Aspinall, R., McElhaney, J. E., Montaño, L. F., Nichol, K. L., Puig‐Barberà, J., Schmitt, J., & Stephenson, I. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.06.032 · Cited by 136
Kong, W., Yen, J.-H. J., & Ganea, D. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.09.012 · Cited by 136
Yan, W., Chen, W., & Huang, L. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.005 · Cited by 131
Self-citationHuang, Z. R., & Szoka, F. C. (2008) · Journal of the American Chemical Society · doi:10.1021/ja8065557 · Cited by 122
Entrapment of proteins in liposomes prevents allergic reactions in pre‐immunised mice
Gregoriadis, G. C., & ALLISON, A. C. (1974) · FEBS Letters · doi:10.1016/0014-5793(74)80813-6 · Cited by 120
Liposome-based cationic adjuvant formulations (CAF): Past, present, and future
Christensen, D., Agger, E. M., Andreasen, L. V., Kirby, D. J., Andersen, P. L., & Perrie, Y. (2009) · Journal of Liposome Research · doi:10.1080/08982100902726820 · Cited by 120
Henriksen‐Lacey, M., Devitt, A., & Perrie, Y. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.05.019 · Cited by 118
Watanabe, J., Miyazaki, Y., Zimmerman, G. A., Albertine, K. H., & McIntyre, T. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307752200 · Cited by 116
Nakanishi, T., Kunisawa, J., Hayashi, A., Tsutsumi, Y. M., Kubo, K., Nakagawa, S., Fujiwara, H., Hamaoka, T., & Mayumi, T. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7749 · Cited by 114
Bekierkunst, A., Levij, I. S., Yarkoni, E., Vilkas, E., & LEDERER, E. (1971) · Science · doi:10.1126/science.174.4015.1240 · Cited by 113
Delivery of lipids and liposomal proteins to the cytoplasm and Golgi of antigen-presenting cells
Rao, M., & Alving, C. R. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00064-2 · Cited by 111
Virosomes for antigen and DNA delivery
Daemen, T., DEMARE, A., Bungener, L. B., de Jonge, J., Huckriede, A. L. W., & Wilschut, J. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.005 · Cited by 109
Archaeosome adjuvants: Immunological capabilities and mechanism(s) of action
Krishnan, L., & Sprott, G. D. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.02.026 · Cited by 108
The RTS,S vaccine candidate for malaria
Regules, J. A., Cummings, J. F., & Ockenhouse, C. F. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.57 · Cited by 108
Henriksen‐Lacey, M., Christensen, D., Bramwell, V. W., Lindenstrøm, T., Agger, E. M., Andersen, P. L., & Perrie, Y. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100208f · Cited by 108
Agnandji, S. T., Asante, K. P., Lyimo, J., Vekemans, J., Soulanoudjingar, S., Owusu, R., Shomari, M., Leach, A. J., Fernandes, J. F., Dosoo, D., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/656190 · Cited by 108
Joseph, A., Itskovitz-Cooper, N., Samira, S., Flasterstein, O., Eliyahu, H., Simberg, D., Goldwaser, I., Barenholz, Y., & Kedar, E. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.12.017 · Cited by 105
Receptor versus non-receptor mediated clearance of liposomes
Scherphof, G. L., & Kamps, J. A. A. M. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00133-6 · Cited by 105
Liposomes as Immunological Adjuvants
ALLISON, A. C., & Gregoriadis, G. (1976) · Springer eBooks · doi:10.1007/978-3-642-81049-7_8 · Cited by 104
Oussoren, C., & Storm, G. (1997) · Pharmaceutical Research · doi:10.1023/a:1012145410859 · Cited by 102
Lipid-based delivery of CpG oligonucleotides enhances immunotherapeutic efficacy
Wilson, K. D., de Jong, S. D., & Tam, Y. K. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.12.014 · Cited by 102
Liposomes as immunological adjuvants and vaccine carriers
Gregoriadis, G., Gürsel, İ., Gürsel, M., & McCormack, B. (1996) · Journal of Controlled Release · doi:10.1016/0168-3659(96)01355-7 · Cited by 100
Omega-3 fatty acids attenuate dendritic cell function via NF-κB independent of PPARγ
Draper, E., Reynolds, C. M., Canavan, M., Mills, K. H. G., Loscher, C. E., & Roche, H. M. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.06.009 · Cited by 100
DiC14‐amidine cationic liposomes stimulate myeloid dendritic cells through Toll‐like receptor 4
Tanaka, T., Legat, A., Adam, E., Steuve, J., Gatot, J., Vandenbranden, M., Ulianov, L., Lonez, C., Ruysschaert, J., Muraille, É., et al. (2008) · European Journal of Immunology · doi:10.1002/eji.200737998 · Cited by 98
Vaxfectin enhances the humoral immune response to plasmid DNA-encoded antigens
Hartikka, J., Bozoukova, V., Ferrari, M. E., Sukhu, L., Enas, J. D., Sawdey, M., Wloch, M. K., Tonsky, K., Norman, J. A., Manthorpe, M., et al. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00445-x · Cited by 97
Guan, H. H., Budzynski, W. A., Koganty, R. R., Krantz, M. J., Reddish, M. A., Rogers, J. A., Longenecker, B. M., & Samuel, J. (1998) · Bioconjugate Chemistry · doi:10.1021/bc970183n · Cited by 96
A Novel Cationic Amphiphile for Transfection of Mammalian Cells
Ruysschaert, J., Elouahabi, A., Willeaume, V., Huez, G. A., Fuks, R., Vandenbranden, M., & DiStefano, P. S. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2372 · Cited by 91
Activation of human monocytic cells by lysophosphatidic acid and sphingosine-1-phosphate
Fueller, M., Wang, D. A., Tigyi, G., & Siess, W. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(02)00117-1 · Cited by 89
Lymphatic uptake and biodistribution of liposomes after subcutaneous injection
Oussoren, C., Velinova, M. J., Scherphof, G. L., van der Want, J. J. L., van Rooijen, N., & Storm, G. (1998) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(97)00275-7 · Cited by 86
Recent Advances in Non‐viral Gene Delivery
Conwell, C. C., & Huang, L. (2005) · Advances in genetics · doi:10.1016/s0065-2660(05)53001-3 · Cited by 82
Self-citationLeroux‐Roels, I., Koutsoukos, M., Clément, F., Steyaert, S., Janssens, M., Bourguignon, P., Cohen, K. W., Altfeld, M. A., Vandepapelière, P., Pedneault, L., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.08.035 · Cited by 78
Comparison of different routes of vaccination for eliciting antibody responses in the human stomach
Johansson, E.-L., Bergquist, C., Edebo, A., Johansson, C., & Svennerholm, A. (2003) · Vaccine · doi:10.1016/j.vaccine.2003.09.002 · Cited by 75
Immunogenicity of liposomal model membranes in mice: dependence on phospholipid composition.
Yasuda, T., Dancey, G. F., & Kinsky, S. C. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.3.1234 · Cited by 75
Vaccination with BLP25 liposome vaccine to treat non-small cell lung and prostate cancers
North, S. A., & Butts, C. A. (2005) · Expert Review of Vaccines · doi:10.1586/14760584.4.3.249 · Cited by 74
Enantiospecific adjuvant activity of cationic lipid DOTAP in cancer vaccine
Vasievich, E. A., Chen, W., & Huang, L. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-0970-1 · Cited by 73
Self-citationPatel, J. D., O’Carra, R., Jones, J., Woodward, J. G., & Mumper, R. J. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9154-7 · Cited by 72
Usonis, V., Bakasénas, V., Valentelis, R., Katiliene, G., Vidzeniene, D., & Herzog, C. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00509-7 · Cited by 72
Immunogenicity of hepatitis B vaccines: implications of immune memory
Koff, R. S. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00405-x · Cited by 72
Chan, L. C., Peters, W., Xu, Y., et al. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0407221 · Cited by 72
Liposomal amphotericin B (AmBisome) for fungal infections in immunocompromised adults and children
Tollemar, J. G., Klingspor, L., & Ringdén, O. T. H. (2001) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2001.tb00012.x · Cited by 71
Novel Method of Greatly Enhanced Delivery of Liposomes to Lymph Nodes
Phillips, W. T., Klipper, R. W., & Goins, B. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38903-7 · Cited by 71
Andrieu, M., Loing, E., Desoutter, J.-F., Connan, F., Choppin, J., Gras‐Masse, H., Hanau, D., Dautry‐Varsat, A., Guillet, J., & Hosmalin, A. (2000) · European Journal of Immunology · doi:10.1002/1521-4141(200011)30:11<3256::aid-immu3256>3.0.co;2-h · Cited by 70
Induction of Cytotoxic T-Lymphocytes and Antitumor Activity by a Liposomal Lipopeptide Vaccine
Chen, W., & Huang, L. (2008) · Molecular Pharmaceutics · doi:10.1021/mp700126c · Cited by 68
Self-citationDIETZ, V. J., Gałazka, A., LOON, F. P. L. V., & Cochi, S. L. (1997) · Europe PMC (PubMed Central) · Cited by 67
Kaur, R., Bramwell, V. W., Kirby, D. J., et al. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.10.012 · Cited by 67
Inflammatory Effects of Endotoxin-Like Contaminants in Commonly Used Protein Preparations
Bito, L. Z. (1977) · Science · doi:10.1126/science.557238 · Cited by 64
Bonilla, D. L., Ly, L. H., Fan, Y., Chapkin, R. S., & McMurray, D. N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010878 · Cited by 63
Bradley, A. J., Brooks, D. E., Norris-Jones, R., & Devine, D. V. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00013-9 · Cited by 62
Liposome‐mediated cytosolic delivery of macromolecules and its possible use in vaccine development
Owais, M., & Gupta, C. M. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01447.x · Cited by 61
Polyvalent Antigens Stabilize B Cell Antigen Receptor Surface Signaling Microdomains
Thyagarajan, R., Arunkumar, N., & Song, W. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.6099 · Cited by 60
Reconstitution of purified detergent-soluble HLA-A and HLA-B antigens into phospholipid vesicles.
Engelhard, V. H., Guild, B. C., Helenius, A., et al. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.7.3230 · Cited by 60
Lysophosphatidylcholine is a natural adjuvant that initiates cellular immune responses
Perrin‐Cocon, L., Agaugué, S., Coutant, F., Saint-Mézard, P., Guironnet‐Paquet, A., Nicolas, J., André, P., & Lotteau, V. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.09.036 · Cited by 59
Nakano, Y., Mori, M., Nishinohara, S., Takita, Y., Naito, S., Kato, H., Taneichi, M., Komuro, K., & Uchida, T. (2001) · Bioconjugate Chemistry · doi:10.1021/bc0001185 · Cited by 59
Lay, M. J., Callejo, B., Chang, S., Hong, D. K., Lewis, D. B., Carroll, T. D., Matzinger, S. R., Fritts, L., Miller, C. J., Warner, J. F., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.054 · Cited by 56
Non‐Viral Vector as Vaccine Carrier
Chen, W. C., & Huang, L. (2005) · Advances in genetics · doi:10.1016/s0065-2660(05)54013-6 · Cited by 55
Self-citationBoeckler, C., Dautel, D., Schelté, P., Frisch, B., Wachsmann, D., Klein, J.-P., & Schuber, F. J. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199907)29:07<2297::aid-immu2297>3.0.co;2-5 · Cited by 55
Mašek, J., Bartheldyová, E., Turánek-Knötigová, P., Škrabalová, M., Korvasová, Z., Plocková, J., Koudelka, Š., Škodová, P., Kulich, P., Křupka, M., et al. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.01.016 · Cited by 54
The role of inflammasomes in the immunostimulatory effects of particulate vaccine adjuvants
Harris, J., Sharp, F. A., & Lavelle, E. C. (2010) · European Journal of Immunology · doi:10.1002/eji.200940172 · Cited by 49
Badiee, A., Jaafari, M. R., Khamesipour, A., Samiei, A., Soroush, D., Kheiri, M. T., Barkhordari, F., McMaster, W. R., & Mahboudi, F. (2009) · Experimental Parasitology · doi:10.1016/j.exppara.2008.12.015 · Cited by 48
Andrieu, M., Desoutter, J.-F., Loing, E., Gaston, J., Hanau, D., Guillet, J., & Hosmalin, A. (2002) · Journal of Virology · doi:10.1128/jvi.77.2.1564-1570.2003 · Cited by 44
Roth, A., Espuelas, S., Thumann, C., Frisch, B., & Schuber, F. J. (2004) · Bioconjugate Chemistry · doi:10.1021/bc034184t · Cited by 43
Zhou, F., & Huang, L. (1994) · ImmunoMethods · doi:10.1006/immu.1994.1025 · Cited by 42
Self-citationEven‐Or, O., Joseph, A., Itskovitz-Cooper, N., Samira, S., Rochlin, E., Eliyahu, H., Goldwaser, I., Balasingam, S., Mann, A., & Lambkin‐Williams, R. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.01.009 · Cited by 41
Peachman, K. K., Rao, M., Palmer, D. R., Zidanic, M., Sun, W., Alving, C. R., & Rothwell, S. W. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.05.013 · Cited by 34
Immunogenicity, protective efficacy and mechanism of novel CCS adjuvanted influenza vaccine
Even‐Or, O., Samira, S., Rochlin, E., Balasingam, S., Mann, A., Lambkin‐Williams, R., Spira, J., Goldwaser, I., Ellis, R., & Barenholz, Y. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.04.011 · Cited by 34
Liposomal-all-trans-retinoic Acid in Treatment of Acute Promyelocytic Leukemia
Özpolat, B., & Lopez‐Berestein, G. (2002) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190290021678 · Cited by 32
CAF01 Potentiates Immune Responses and Efficacy of an Inactivated Influenza Vaccine in Ferrets
Martel, C. J., Agger, E. M., Poulsen, J. J., Jensen, T. H., Andresen, L. O., Christensen, D., Nielsen, L. P., Blixenkrone-Møller, M., Andersen, P. L., & Aasted, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022891 · Cited by 31
Lipid-Protamine-DNA-Mediated Antigen Delivery
Vangasseri, D., Han, S., & Huang, L. (2005) · Current Drug Delivery · doi:10.2174/156720105774370168 · Cited by 31
Self-citationCharacterization of immunogenic properties of haptenated liposomal model membranes in mice.
Aj, V. H., Snippe, H., Peulen, G. T., & Willers, J. M. N. (1981) · PubMed · Cited by 26
Peachman, K. K., Rao, M., Alving, C. R., Palmer, D. R., Sun, W., & Rothwell, S. W. (2005) · Immunobiology · doi:10.1016/j.imbio.2005.06.002 · Cited by 24
Yotsumoto, S., Aramaki, Y., Kakiuchi, T., & TSUCHIYA, S. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.01.071 · Cited by 23
Antigen–Specific, IgE–Selective Unresponsiveness Induced by Antigen–Liposome Conjugates
Nakano, Y., Mori, M., Nishinohara, S., et al. (1999) · International Archives of Allergy and Immunology · doi:10.1159/000024268 · Cited by 18
Kraaijeveld, C. A., Schilham, M. W., Jansen, J., Benaissa-Trouw, B. J., Harmsen, M., van Houte, A. J., & Snippe, H. (1984) · PubMed · Cited by 17
DiC14-amidine confers new anti-inflammatory properties to phospholipids
Lonez, C., Legat, A., Vandenbranden, M., & Ruysschaert, J. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7520-1 · Cited by 16
Rothwell, S. W., Wassef, N. M., Alving, C. R., & Rao, M. (2000) · Immunology Letters · doi:10.1016/s0165-2478(00)00206-6 · Cited by 16
Ahmad, N., Deeba, F., Faisal, S. M., Khan, A. A., Agrewala, J. N., Dwivedi, V., & Owais, M. (2006) · Biochimie · doi:10.1016/j.biochi.2006.04.017 · Cited by 12
Vesicular carrier constructs for topical immunisation
Vyas, S. P., Khatri, K., & Mishra, D. V. (2007) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.4.4.341 · Cited by 7
Cited by
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
New developments in liposomal drug delivery
Pattni, B. S., Chupin, V. V., & Torchilin, V. P. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00046 · Cited by 1,600
Liu, P., Chen, G., & Zhang, J. (2022) · Molecules · doi:10.3390/molecules27041372 · Cited by 1,334
Zhao, L., Seth, A., Wibowo, N., Zhao, C.-X., Mitter, N., Yu, C., & Middelberg, A. P. J. (2014) · Vaccine · doi:10.1016/j.vaccine.2013.11.069 · Cited by 919
Synthetic Nanoparticles for Vaccines and Immunotherapy
Irvine, D. J., Hanson, M. C., Rakhra, K., & Tokatlian, T. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00109 · Cited by 763
Metadata
- Authors
- Watson, D. S., Endsley, A. N., & Huang, L.
- Venue
- Vaccine
- Publisher
- Elsevier BV
- Published
- 2012-03
- Volume
- 30
- Issue
- 13
- Pages
- 2256-2272
- ISSN
- 0264-410X (ISSN-L)
- OpenAlex
- W1982661859
- Cited by
- 322
- References
- 192
- FWCI
- 11.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.